ClearPoint Neuro Inc.
CLPT
Jodie situation report
ClearPoint Neuro Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 28 of 31 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- At least 21 of 31 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as NRIX begins moving with the group.
Invalidation: The live read weakens if participation falls to 10 of 31 members or fewer.
Who this business touches
The relationships behind CLPT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
PTCTPTC Therapeutics, Inc.supplierNov 4, 2025 ▾
“In January 2020, the Company purchased a $ 10.0 million convertible note from ClearPoint that was convertible into ClearPoint shares at a conversion rate of $ 6.00 per share at any point throughout the term of the loan, with a maturity date five years from th…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CLPT is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.